SELECTIVE ELIMINATION OF EROSIVE CELLS
The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
16.03.2017
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody. |
|---|---|
| AbstractList | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody. |
| Author | GALSGAARD ELISABETH DOUGLAS SOEDERSTROEM KALLE |
| Author_xml | – fullname: SOEDERSTROEM KALLE – fullname: GALSGAARD ELISABETH DOUGLAS |
| BookMark | eNrjYmDJy89L5WRQC3b1cXUO8QxzVXD18fT19HMM8fT3U_B3U3AN8g8GCTu7-vgE8zCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwNDcwNzYxNDc0dDY-JUAQBCQSZB |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2017073417A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2017073417A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:02:24 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2017073417A13 |
| Notes | Application Number: US201615355087 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170316&DB=EPODOC&CC=US&NR=2017073417A1 |
| ParticipantIDs | epo_espacenet_US2017073417A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20170316 |
| PublicationDateYYYYMMDD | 2017-03-16 |
| PublicationDate_xml | – month: 03 year: 2017 text: 20170316 day: 16 |
| PublicationDecade | 2010 |
| PublicationYear | 2017 |
| RelatedCompanies | NOVO NORDISK A/S |
| RelatedCompanies_xml | – name: NOVO NORDISK A/S |
| Score | 3.0813704 |
| Snippet | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| Title | SELECTIVE ELIMINATION OF EROSIVE CELLS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170316&DB=EPODOC&locale=&CC=US&NR=2017073417A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlILSt6KxTVofirg0ZUq3jrUdexttWkGQOVzFf99L1ume9pbk4PIBv_tI7i4At9KWJXVVXBihpeU8ENt6LCS10FWgaEHkuaejCQdD1s-c1ymdtuBjnQuj64T-6OKIiCiJeK-1vF78X2IFOrZyeVe849DnU5j6gdl4x0RVY2dm0PPFKA5ibnLuZ4k5HK9oLops9xl9pR00pF2FBzHpqbyUxaZSCQ9hd4T85vURtKp5B_b5-u-1DuwNmidvbDboWx6DmYhI8PRlIgyhhM6qkq0Rh4YYx4ka5iKKkhO4CUXK-xZOOPvb3yxLNldnn0IbPf_qDAyvciVhb-V9XhAH7focxZokBaME9Tr17HPobuN0sZ18CQeqqwKqCOtCu_76rq5Qw9bFtT6YXxpgeNw |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakDJLeiabBIPQexmQ6p5lCYpvYW8BEFqsRH_vrNpqj31tszA7APmm5ndmVmA20ItSmqIvDBCS0V7IKrymBdUwVCBogeRZWaTTegHuptoLzM668DHuham6RP60zRHRI0qUN_rBq8X_5dYdpNbubzL35H0-eTEli230TER3dh12R5afBzaIZMZs5JIDiYrnoGQbTxjrLSDTrYh9IFPh6IuZbFpVJwD2B2jvHl9CJ1q3oceW_-91oc9v33yxmGrfcsjkCPucRaPplziAnRWnWyl0JH4JIwEmXHPi47hxuExcxWcMP3bX5pEm6tTT6CLkX91CpJZGQXR38r7LCca-vUZwlpBcp0StOvUVM9gsE3S-Xb2NfTc2PdSbxS8XsC-YInkKqIPoFt_fVeXaG3r_Ko5pF_wOnvP |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SELECTIVE+ELIMINATION+OF+EROSIVE+CELLS&rft.inventor=SOEDERSTROEM+KALLE&rft.inventor=GALSGAARD+ELISABETH+DOUGLAS&rft.date=2017-03-16&rft.externalDBID=A1&rft.externalDocID=US2017073417A1 |